Immunohistochemical Analysis of the Metabolic Phenotype of Adrenal Cortical Carcinoma

Metabolic reprogramming is a cellular process contributing to carcinogenesis. However, it remains poorly understood in adrenal cortical carcinoma (ACC), an aggressive malignancy with overall poor prognosis and limited therapeutic options. We characterized the metabolic phenotype of ACC, by examining...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Endocrine pathology 2020-09, Vol.31 (3), p.231-238
Hauptverfasser: Duan, Kai, Gucer, Hasan, Kefeli, Mehmet, Asa, Sylvia L., Winer, Daniel A., Mete, Ozgur
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Metabolic reprogramming is a cellular process contributing to carcinogenesis. However, it remains poorly understood in adrenal cortical carcinoma (ACC), an aggressive malignancy with overall poor prognosis and limited therapeutic options. We characterized the metabolic phenotype of ACC, by examining the immunoprofile of key proteins involved in glucose metabolism, hexokinase (HK1), pyruvate kinase (PKM1, PKM2), succinate dehydrogenase (SDHB), and phospho-S6 ribosomal protein (pS6), in a tissue microarray of 137 adrenal cortical tissue samples. Protein expression was compared between ACC ( n  = 42), adrenal cortical adenoma (ACA; n  = 50), and normal adrenal cortical tissue samples ( n  = 45). Cytoplasmic expression of HK1 and PKM2 was significantly higher in ACC than in ACA ( p  
ISSN:1046-3976
1559-0097
DOI:10.1007/s12022-020-09624-3